RAYLUMIS Trademark

Trademark Overview

On Friday, June 16, 2017, a trademark application was filed for RAYLUMIS with the United States Patent and Trademark Office. The USPTO has given the RAYLUMIS trademark a serial number of 87492521. The federal status of this trademark filing is REGISTERED as of Tuesday, October 20, 2020. This trademark is owned by Pfizer Inc.. The RAYLUMIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain; none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs)
raylumis

General Information

Serial Number87492521
Word MarkRAYLUMIS
Filing DateFriday, June 16, 2017
Status700 - REGISTERED
Status DateTuesday, October 20, 2020
Registration Number6180502
Registration DateTuesday, October 20, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain; none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2017
Primary Code005
First Use Anywhere DateWednesday, July 1, 2020
First Use In Commerce DateWednesday, July 1, 2020

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 20, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, September 17, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 16, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 15, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 1, 2020USE AMENDMENT FILED
Tuesday, September 15, 2020SOU EXTENSION 4 GRANTED
Monday, August 24, 2020SOU EXTENSION 4 FILED
Tuesday, September 1, 2020TEAS STATEMENT OF USE RECEIVED
Monday, August 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 24, 2020TEAS EXTENSION RECEIVED
Wednesday, February 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 24, 2020SOU EXTENSION 3 GRANTED
Monday, February 24, 2020SOU EXTENSION 3 FILED
Monday, February 24, 2020TEAS EXTENSION RECEIVED
Monday, February 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, September 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2019SOU EXTENSION 2 GRANTED
Thursday, September 12, 2019SOU EXTENSION 2 FILED
Thursday, September 12, 2019TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 14, 2019SOU EXTENSION 1 GRANTED
Thursday, February 14, 2019SOU EXTENSION 1 FILED
Thursday, February 14, 2019TEAS EXTENSION RECEIVED
Tuesday, October 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 15, 2018OPPOSITION TERMINATED NO. 999999
Wednesday, August 15, 2018OPPOSITION DISMISSED NO. 999999
Monday, April 9, 2018OPPOSITION INSTITUTED NO. 999999
Saturday, February 17, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, February 9, 2018ASSIGNED TO PETITION STAFF
Monday, January 29, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, November 9, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2017ASSIGNED TO EXAMINER
Thursday, June 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 20, 2017NEW APPLICATION ENTERED

Related Keywords

raylumis treatment tumors conditions arteriovenous malformations avms system embolization pain preparations